Showing results (71-80 of 155) with videos related to
Sort By:
Pageof 16
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1988
Growth hormone (GH) secretion during nocturnal sleep and after clonidine in patients with essential hypertensionJ Słowińska-Srzednicka, S Zgliczyński, M Wierzbicki, et al.The American Journal of Cardiology|September 16, 1998
Low-molecular-weight heparins: pharmacologic profile and product differentiationJ Fareed, W Jeske, D Hoppensteadt, et al.Seminars in Thrombosis and Hemostasis|January 1, 1996
Are the available low-molecular-weight heparin preparations the same?J Fareed, W Jeske, D Hoppensteadt, et al.The Canadian Journal of Cardiology|October 21, 1998
Low molecular weight heparins: are they different?J Fareed, D Hoppensteadt, W Jeske, et al.Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
High blood pressure and hyperinsulinaemia in acromegaly and in obesityJ Słowińska-Srzednicka, S Zgliczyński, P Soszyński, et al.Acta Endocrinologica|October 1, 1987
The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesityB Baranowska, S P Singh, P Soszynski, et al.Wiener Klinische Wochenschrift|July 18, 1975
[Studies in the diagnosis of breast disease (author's transl)]R Kolb, A Priesching, W Czech, et al.Environmental Toxicology and Chemistry|January 5, 2002
Lead poisoning in the globally threatened marbled teal and white-headed duck in SpainR Mateo, A J Green, C W Jeske, et al.Seminars in Thrombosis and Hemostasis|January 1, 1995
Pharmacologic validation of the clinical effects of an optimized low-molecular-weight heparin-reviparinJ Fareed, W Jeske, V Eschenfelder, et al.Acta Endocrinologica|October 1, 1985
The effect of naloxone on ATCH and beta-endorphin in patients with Cushing's diseaseB Baranowska, W Dorobek, W Misiorowski, et al.Pageof 16